Scholarlink

Background <p>This study explored the effect of blackberry fruit extract (BFE) and metformin (Met) on biochemical markers, redox parameters, and the downstream insulin signaling pathway in a high-fat diet (HFD) + streptozotocin (STZ) induced Type 2 Diabetic Rat model.</p> Methods <p>The identification and quantification of cyanidin-3-glucoside by HPLC in the BFE revealed a concentration of 28.33 ± 0.05&#xa0;mg/g of dry extract. For in vivo study, Type 2 Diabetes Mellitus (T2DM) was induced in rats by feeding a HFD for 3 weeks, followed by a single intraperitoneal dose of STZ on day 21. Animals were divided into 4 groups: I – Control, II – T2DM, III – T2DM plus Met (250&#xa0;mg/kg) and IV – T2DM plus BFE (200&#xa0;mg/kg). After STZ administration, the animals underwent a glucose tolerance test. Biochemical and molecular analyses were performed in serum and brain tissues.</p> Results <p>BFE and Met improved diabetic parameters, mitigating hyperglycemia, dyslipidemia, and inflammation by lowering serum glucose, total cholesterol, triglycerides, very low-density lipoprotein, interleukin-6, adenosine deaminase activity, and reactive species levels, while restoring high-density lipoprotein and paraoxonase-1 activity in blood. Both treatments reduced oxidative stress in the cerebral cortex by lowering reactive species, nitrite, and thiobarbituric acid reactive substances levels and increasing sulfhydryl groups, superoxide dismutase and catalase activity. Also, BFE upregulated phosphatidylinositol 3-kinase, insulin receptor substrate-1, forkhead box O-3a in the cerebral cortex.</p> Conclusion <p>These findings highlight the potential of BFE as a promising natural therapeutic agent for T2DM management, demonstrating efficacy comparable to Met in addressing metabolic and oxidative impairments.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Modulatory role of blackberry fruit standardized extract on brain redox status and insulin signaling in type 2 diabetic rats

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月3日

查看全文
  • Imtiaz Ahmad,
  • Julia Eisenhardt de Mello,
  • Larissa Menezes da Silveira,
  • Mayara Sandrielly Soares de Aguiar,
  • Marcia Vizzotto,
  • William Borges Domingues,
  • Lucas Petitemberte de Souza,
  • Vinicius Farias Campos,
  • Rejane Giacomelli Tavares,
  • Roselia Maria Spanevello,
  • Francieli Moro Stefanello

摘要

Background

This study explored the effect of blackberry fruit extract (BFE) and metformin (Met) on biochemical markers, redox parameters, and the downstream insulin signaling pathway in a high-fat diet (HFD) + streptozotocin (STZ) induced Type 2 Diabetic Rat model.

Methods

The identification and quantification of cyanidin-3-glucoside by HPLC in the BFE revealed a concentration of 28.33 ± 0.05 mg/g of dry extract. For in vivo study, Type 2 Diabetes Mellitus (T2DM) was induced in rats by feeding a HFD for 3 weeks, followed by a single intraperitoneal dose of STZ on day 21. Animals were divided into 4 groups: I – Control, II – T2DM, III – T2DM plus Met (250 mg/kg) and IV – T2DM plus BFE (200 mg/kg). After STZ administration, the animals underwent a glucose tolerance test. Biochemical and molecular analyses were performed in serum and brain tissues.

Results

BFE and Met improved diabetic parameters, mitigating hyperglycemia, dyslipidemia, and inflammation by lowering serum glucose, total cholesterol, triglycerides, very low-density lipoprotein, interleukin-6, adenosine deaminase activity, and reactive species levels, while restoring high-density lipoprotein and paraoxonase-1 activity in blood. Both treatments reduced oxidative stress in the cerebral cortex by lowering reactive species, nitrite, and thiobarbituric acid reactive substances levels and increasing sulfhydryl groups, superoxide dismutase and catalase activity. Also, BFE upregulated phosphatidylinositol 3-kinase, insulin receptor substrate-1, forkhead box O-3a in the cerebral cortex.

Conclusion

These findings highlight the potential of BFE as a promising natural therapeutic agent for T2DM management, demonstrating efficacy comparable to Met in addressing metabolic and oxidative impairments.

Graphical abstract